EXECUTION VERSION CREDIT AGREEMENT Dated as of September 18, 2018 among CANCER GENETICS, INC. as Borrower and NOVELLUSDX, LTD. as Lender CREDIT AGREEMENTCredit Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionThis Credit Agreement (as it may be amended, restated, supplemented, or modified and in effect from time to time, this “Agreement”), dated as of September 18, 2018 is entered into by and between Cancer Genetics, Inc., a Delaware corporation (together with its successors and permitted assigns, “Borrower”) and NovellusDX, Ltd., a company established under the laws of the State of Israel (“Lender”).
CREDIT AGREEMENT Dated as of September 18, 2018 amongCredit Agreement • September 21st, 2018 • Cancer Genetics, Inc • Services-medical laboratories • Delaware
Contract Type FiledSeptember 21st, 2018 Company Industry JurisdictionThis Credit Agreement (as it may be amended, restated, supplemented, or modified and in effect from time to time, this “Agreement”), dated as of September 18, 2018 is entered into by and between Cancer Genetics, Inc., a Delaware corporation (together with its successors and permitted assigns, “Borrower”) and NovellusDX, Ltd., a company established under the laws of the State of Israel (“Lender”).